10Indexed trials
mesh condition
Tauopathies
Intelligence
Tauopathies intelligence: 10 indexed trials, 1 recruiting studies, 10 sponsors across 28 countries.
1Recruiting
10Sponsors
28Countries
Leading sponsors
Affiris AG10 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Limited10 recruiting
Elizabeth K Rhodus10 recruiting
Hoffmann-La Roche10 recruiting
Jae Seung Kim10 recruiting
MODAG GmbH10 recruiting
MapLight Therapeutics11 recruiting
Sinotau Pharmaceutical Group10 recruiting
Tammie L. S. Benzinger, MD, PhD10 recruiting
Geographic activity
United States4trials
South Korea3trials
France3trials
China2trials
Canada2trials
United Kingdom2trials
Italy2trials
Czechia2trials
Poland2trials
Germany2trials
Slovakia2trials
Croatia1trials
Leading interventions
E20202trials
Crenezumab1trials
Drug: [18F]florbetaben1trials
F 18 T8071trials
Fluvoxamine 100 mg QD for 5 days1trials
Harmony at HOME (H@H)1trials
ML-007C-MA1trials
[18F]PI-26201trials
AFFITOPE® AD021trials
anle138b (TEV-56286)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.